Earnings History Data for Larimar Therapeutics, Inc. (LRMR) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Larimar Therapeutics, Inc.

Larimar Therapeutics Inc. is a clinical-stage biotechnology company. It is focused on developing treatments for rare diseases. The company's lead product consist CTI-1601, which is in clinical stage. Larimar Therapeutics Inc., formerly known as Zafgen Inc., is based in BALA CYNWYD, Pa.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
10-11-2022 PM Before the open
(Nov 10)
LRMR Larimar Therapeutics 50.00 -0.37 -0.50 0.00 Larimar Therapeutics GAAP EPS of -$0.37 beats by $0.12
[11/10/2022 8:48 AM]
3.13 0.17 
(5.78%)
0.0 0.0 
(0.00%)
1.53 - 13.57 27,515 90,000 0
12-05-2022 PM LRMR Larimar Therapeutics 52.00 -0.49 -0.62 0.00 Larimar Therapeutics GAAP EPS of -$0.49
[5/12/2022 8:22 AM]
2.56 -0.22 
(-7.91%)
2.78 0.0 
(0.00%)
2.46 - 15.49 53,534 70,000 7,073
25-03-2022 PM LRMR Larimar Therapeutics, Inc. 73.85 -0.50 0.00 -0.89 Larimar Therapeutics GAAP EPS of -$0.50 beats by $0.22
[3/25/2022 7:26 AM]
3.99 0.02 
(0.46%)
0.0 0.0 
(0.00%)
2.71 - 17.37 37,537 225,640 0
12-11-2021 PM LRMR Larimar Therapeutics 231.00 -0.92 -0.62 0.00 Larimar Therapeutics EPS misses by $0.25
[11/12/2021 7:48 AM]
11.46 -1.04 
(-8.32%)
12.50 0.0 
(0.00%)
7.00 - 25.87 59,570 20,000 156
12-08-2021 PM LRMR Larimar Therapeutics, Inc. 160.00 -0.79 -0.73 0.00 Larimar Therapeutics EPS misses by $0.04
[8/12/2021 7:47 AM]
12.98 1.96 
(17.79%)
0.0 0.0 
(0.00%)
7.00 - 25.87 373,997 110,000 0
10-05-2021 AH After the close
(May 10)
LRMR Larimar Therapeutics, Inc. 210.00 -0.76 -0.93 0.00 Larimar Therapeutics EPS beats by $0.10
[5/10/2021 4:39 PM]
8.42 -4.70 
(-35.82%)
11.00 -2.12 
(-16.16%)
8.42 - 25.87 513,392 30,000 94,483
04-03-2021 PM LRMR Larimar Therapeutics, Inc. 262.13 -0.89 -0.72 -1.80 Larimar Therapeutics reports Q4 results
[3/4/2021 7:31 AM]
16.94 -0.31 
(-1.80%)
17.00 -0.25 
(-1.45%)
7.43 - 25.87 95,249 65,105 2,200
10-11-2020 PM LRMR Larimar Therapeutics, Inc. 303.75 -0.64 0.00 -2.88 Larimar Therapeutics reports Q3 results
[11/10/2020 8:09 AM]
20.40 0.79 
(4.03%)
0.0 0.0 
(0.00%)
7.43 - 22.45 7,879 47,291 0